New imaging agent could sharpen multiple myeloma detection
NCT ID NCT04561492
First seen Dec 16, 2025 · Last updated May 20, 2026 · Updated 18 times
Summary
This study is testing whether a new radioactive tracer called PentixaFor can improve PET scans for people with multiple myeloma. The goal is to see if it finds cancer spots better than the standard FDG tracer, both at first diagnosis and when the disease comes back. About 45 adults with symptomatic myeloma will be scanned and followed to compare accuracy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APHP - Site Tenon
Paris, France
-
CHU Bordeaux
Bordeaux, France
-
Nantes UH
Nantes, France
Conditions
Explore the condition pages connected to this study.